183 related articles for article (PubMed ID: 25901437)
1. Adjuvant ovarian suppression in premenopausal breast cancer.
Francis PA; Regan MM; Fleming GF
N Engl J Med; 2015 Apr; 372(17):1673. PubMed ID: 25901437
[No Abstract] [Full Text] [Related]
2. Adjuvant ovarian suppression in premenopausal breast cancer.
Montemurro F; Perrone F; Geuna E
N Engl J Med; 2015 Apr; 372(17):1672-3. PubMed ID: 25901438
[No Abstract] [Full Text] [Related]
3. Adjuvant ovarian suppression in premenopausal breast cancer.
Francis PA; Regan MM; Fleming GF; Láng I; Ciruelos E; Bellet M; Bonnefoi HR; Climent MA; Da Prada GA; Burstein HJ; Martino S; Davidson NE; Geyer CE; Walley BA; Coleman R; Kerbrat P; Buchholz S; Ingle JN; Winer EP; Rabaglio-Poretti M; Maibach R; Ruepp B; Giobbie-Hurder A; Price KN; Colleoni M; Viale G; Coates AS; Goldhirsch A; Gelber RD; ;
N Engl J Med; 2015 Jan; 372(5):436-46. PubMed ID: 25495490
[TBL] [Abstract][Full Text] [Related]
4. Deep time: the long and the short of adjuvant endocrine therapy for breast cancer.
Burstein HJ; Griggs JJ
J Clin Oncol; 2012 Mar; 30(7):684-6. PubMed ID: 22271478
[No Abstract] [Full Text] [Related]
5. Perfecting breast-cancer treatment--incremental gains and musculoskeletal pains.
Hershman DL
N Engl J Med; 2015 Jan; 372(5):477-8. PubMed ID: 25495491
[No Abstract] [Full Text] [Related]
6. Exemestane with ovarian suppression in premenopausal breast cancer.
Prasad V
N Engl J Med; 2014 Oct; 371(14):1358. PubMed ID: 25271613
[No Abstract] [Full Text] [Related]
7. Exemestane with ovarian suppression in premenopausal breast cancer.
Chlebowski RT; Pan K
N Engl J Med; 2014 Oct; 371(14):1358. PubMed ID: 25271612
[No Abstract] [Full Text] [Related]
8. Exemestane with ovarian suppression in premenopausal breast cancer.
Amoroso V; Berruti A; Simoncini E
N Engl J Med; 2014 Oct; 371(14):1357. PubMed ID: 25271611
[No Abstract] [Full Text] [Related]
9. Exemestane with ovarian suppression in premenopausal breast cancer.
Pagani O; Regan MM; Francis PA; ;
N Engl J Med; 2014 Oct; 371(14):1358-9. PubMed ID: 25271610
[No Abstract] [Full Text] [Related]
10. Overview of adjuvant trials of aromatase inhibitors in early breast cancer.
Ingle JN
Steroids; 2011 Jul; 76(8):765-7. PubMed ID: 21382394
[TBL] [Abstract][Full Text] [Related]
11. Are SOFT and TEXT results practice changing and how?
Pagani O; Regan MM; Francis PA
Breast; 2016 Jun; 27():122-5. PubMed ID: 27107153
[TBL] [Abstract][Full Text] [Related]
12. Update: a 62-year-old woman with a new diagnosis of breast cancer.
Farag N; Burns R; Come SE
JAMA; 2008 Mar; 299(9):1055-6. PubMed ID: 18319415
[No Abstract] [Full Text] [Related]
13. [New results of endocrine therapy of breast cancer (the role of Aromasin)].
Semiglazov VF; Semiglazov VV; Klemtsel' AA; Barash NIu; Zhil'tsova EK; Bozhok AA; Mel'nikova OA; Paltuev RM; Dashian GA; Petrovskiĭ SG; Ivanov VG; Tonuzov EE; Berstein LM
Vopr Onkol; 2004; 50(6):729-36. PubMed ID: 15755074
[No Abstract] [Full Text] [Related]
14. Role of obesity on the efficacy of exemestane plus ovarian suppression in hormone receptor-positive premenopausal breast cancer.
Şendur MA; Aksoy S; Akıncı MB; Ozdemir N; Dede DŞ; Altundag K; Zengin N; Yalçın B
Future Oncol; 2015; 11(6):905-7. PubMed ID: 25760972
[No Abstract] [Full Text] [Related]
15. Exemestane following tamoxifen in postmenopausal women with primary breast cancer.
Mouridsen HT
J Clin Oncol; 2004 Sep; 22(18):3833-4. PubMed ID: 15365083
[No Abstract] [Full Text] [Related]
16. Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen.
Ruddy KJ; DeSantis SD; Barry W; Guo H; Block CC; Borges V; Winer EP; Partridge AH
Clin Breast Cancer; 2014 Dec; 14(6):413-6. PubMed ID: 24970714
[TBL] [Abstract][Full Text] [Related]
17. [Advancement in endocrine therapy for breast cancer].
Yang MT; Lian ZQ
Ai Zheng; 2007 Apr; 26(4):440-4. PubMed ID: 17430670
[TBL] [Abstract][Full Text] [Related]
18. Exemestane or tamoxifen?
Atkins CD
Lancet; 2007 May; 369(9573):1600; author reply 1600-1. PubMed ID: 17499597
[No Abstract] [Full Text] [Related]
19. Switching to aromatase inhibitors in early breast cancer.
Boccardo F; Rubagotti A
Lancet; 2007 Feb; 369(9561):533-5. PubMed ID: 17307082
[No Abstract] [Full Text] [Related]
20. Can exemestane improve adjuvant treatment for postmenopausal women with primary breast cancer?
Hutchinson L
Nat Clin Pract Oncol; 2004 Nov; 1(1):24-5. PubMed ID: 16264795
[No Abstract] [Full Text] [Related]
[Next] [New Search]
